Hiroyuki Hanai ¹, Ken Takeuchi, Takayuki Iida, Nobuhito Kashiwagi, Abby R Saniabadi, Isao Matsushita, Yoshihiko Sato, Naoki Kasuga, Toshihiro Nakamura, Dig Dis Sci. 2004 Sep;49(9):1438-43.

In conclusion, GM appear to contribute to intestinal inflammation and UC activity and reduction of these cells by GMA should benefit patients with active UC. Further, the correlations among calprotectin, UC activities, and PB neutrophils should serve as the basis for preemptive actions to control this disease.

https://pubmed.ncbi.nlm.nih.gov/15481316/